Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MicroRNAs: A potential new frontier for medicine

24.03.2011
Noted experts explore this topic in the April issue of Translational Research

Since their discovery in the 1990s, microRNAs have proven to play a complex role in normal and abnormal functioning of many organ systems. In the April issue of Translational Research, entitled "MicroRNAs: A Potential New Frontier for Medicine," an international group of medical experts explores several themes related to our current understanding of microRNAs and the role they may play in the future of medicine.

A commentary by Monty Montano, Department of Medicine, Boston University, provides a general introduction to this single-topic issue. He states, "In the coming years, there is much to be learned about adaptive (and maladaptive) states by examining how the expression of miRNAs is influenced by the genetic architecture of miR genes, clusters, and mirtrons, as well as miRNA polymorphism and polymorphism in their mRNA targets…Current efforts to leverage knowledge of this regulatory system to diagnose, track, and attenuate disease progression represent a major new research opportunity and challenge in this rapidly growing area of translational medicine."

KEY POINTS:

microRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases
Rujuan Dai, and S. Ansar Ahmed
The authors review in great detail the functions of microRNAs in autoimmune diseases, inflammation processes, and immune system regulation.
Integrating microRNAs into a system biology approach to acute lung injury
Tong Zhou, Joe G.N. Garcia and Wei Zhang
The authors explore the possible role of microRNAs in inflammatory lung diseases and integration into a comprehensive disease model for acute lung injury.
MicroRNAs in idiopathic pulmonary fibrosis
Kusum V. Pandit, Jadranka Milosevic and Naftali Kaminski
The authors summarize current knowledge on the role of microRNAs in idiopathic lung fibrosis (IPF), highlighting how differentially expressed microRNAs in IPF will have a significant impact on our understanding of the disease.
Involvement of microRNAs in lung cancer biology and therapy
Xi Liu, Lorenzo F. Sempere, Yongli Guo, Murray Korc, Sakari Kauppinen, Sarah J. Freemantle and Ethan Dmitrovsky

The authors review how microRNAs can accelerate or suppress lung cancers and how this knowledge might serve as a basis for developing diagnostic markers or anti-cancer therapeutic agents.

MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe?
Sai Yendamuri and Robert Kratzke
The authors explore some of the difficulties facing the development of microRNAs as biomarkers for lung disease, as well as some promising areas of research.
MicroRNAs as therapeutic targets in cancer
S. Patrick Nana-Sinkam and Carlo M. Croce
The authors review the challenges of translating current knowledge on microRNAs into effective clinical therapies for many cancers or as adjuvants for enhancing chemosensitivity to traditional therapies.
MicroRNAs in cardiac disease
Gerald W. Dorn II
The author examines the use of microRNAs as both biomarkers of cardiac diseases and as potential targets for therapies.
MicroRNAs in kidney function and disease
Sanjeev Akkina and Bryan N. Becker
The authors review the role of microRNAs in understanding the pathophysiology of kidney disease and potential therapeutic uses.
microRNAs and liver disease
Thomas A. Kerr, Kevin M. Korenblat and Nicholas O. Davidson
The authors review developments in microRNA research in the areas of pathogenesis of nonalcoholic fatty liver disease (NAFLD), viral hepatitis (C and B), and hepatocellular carcinoma (HCC), as well as the role of miRNAs as biomarkers of liver injury and HCC.
Diabetes mellitus, a microRNA-related disease?
Claudiane Guay, Elodie Roggli, Valeria Nesca, Cécile Jacovetti and Romano Regazzi

The authors review recent studies on the role of microRNAs in the pathogenesis of diabetes, including the role of several microRNAs in pancreatic beta cells and insulin-target tissues.

These articles appear in Translational Research, The Journal of Laboratory and Clinical Medicine, Volume 157, Issue 4 (April 2011) entitled "MicroRNAs: A Potential New Frontier for Medicine," published by Elsevier.

Pat Hogan | EurekAlert!
Further information:
http://www.elsevier.com

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>